AstraZeneca Plc has appointed Aradhana Sarin as chief financial officer subject to the closing of the company’s acquisition of Alexion Pharmaceuticals, a US specialty pharmaceutical company. Dr Sarin is currently CFO at Alexion. She will relocate from the US and be based in the UK reporting to Pascal Soriot, the AstraZeneca chief executive.
Concurrently, Marc Dunoyer will step down as AstraZeneca CFO to become chief executive at Alexion and chief strategy officer for the enlarged group. He will continue to report to Mr Soriot. Before joining Alexion, Dr Sarin had a career in banking at Citigroup, UBS and JP Morgan. She trained as a medical doctor in India and spent two years practising in India and in countries in Africa.
AstraZeneca announced the management changes on 4 June 2021.
Copyright 2021 Evernow Publishing Ltd